[44/47Sc]Sc3+, [68Ga]Ga3+, and [111In]In3+ are the three most attractive
trivalent smaller radiometalnuclides, offering a wide range of distinct
properties (emission energies and types) in the toolbox of nuclear
medicine. In this study, all three of the metal ions are successfully
chelated using a new oxine-based hexadentate ligand, H3glyox, which forms thermodynamically stable neutral complexes with
exceptionally high pM values [pIn (34) > pSc (26) > pGa (24.9)].
X-ray
diffraction single crystal structures with stable isotopes revealed
that the ligand is highly preorganized and has a perfect fit to size
cavity to form [Sc(glyox)(H2O)] and [In(glyox)(H2O)] complexes. Quantitative radiolabeling with gallium-68 (RCY >
95%, [L] = 10–5 M) and indium-111 (RCY > 99%,
[L]
= 10–8 M) was achieved under ambient conditions
(RT, pH 7, and 15 min) with very high apparent molar activities of
750 MBq/μmol and 650 MBq/nmol, respectively. Preliminary quantitative
radiolabeling of [44Sc]ScCl3 (RCY > 99%,
[L]
= 10–6 M) was fast at room temperature (pH 7 and
10 min). In vitro experiments revealed exceptional
stability of both [68Ga]Ga(glyox) and [111In]In(glyox)
complexes against human serum (transchelation <2%) and its suitability
for biological applications. Additionally, on chelation with metal
ions, H3glyox exhibits enhanced fluorescence, which was
employed to determine the stability constants for Sc(glyox) in addition
to the in-batch UV–vis spectrophotometric titrations; as a
proof-of-concept these complexes were used to obtain fluorescence
images of live HeLa cells using Sc(glyox) and Ga(glyox), confirming
the viability of the cells. These initial investigations suggest H3glyox to be a valuable chelator for radiometal-based diagnosis
(nuclear and optical imaging) and therapy.